EX-32 8 v337844_ex32.htm EXHIBIT 32

Exhibit 32



Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intercept Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:


The Annual Report for the year ended December 31, 2012 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.




Dated: April 1, 2013                                       /s/ Mark Pruzanski                                

Mark Pruzanski, M.D.

President and Chief Executive Officer

(Principal Executive Officer)





Dated: April 1, 2013                                        /s/ Barbara Duncan      

Barbara G. Duncan

Chief Financial Officer

(Principal Financial Officer)